Written Question · S7W-05118 · Session 7
How many patients are currently receiving disease-modifying therapies for (a) relapsing multiple sclerosis and (b) primary progressive mult…
The question
To ask the Scottish Government how many patients are currently receiving disease-modifying therapies for (a) relapsing multiple sclerosis and (b) primary progressive multiple sclerosis in the (i) NHS Forth Valley area and (ii) NHS Lothian area, and, of those patients, what proportion receive their treatments in a (A) hospital setting compared with (B) community or home setting.
The answer
Awaiting answer, due 26 Nov 2026. Lodged 12 Nov 2026.
In the Official Report
No contribution in the Official Report cites S7W-05118 by reference.